pubmed-article:20830287 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20830287 | lifeskim:mentions | umls-concept:C0027361 | lld:lifeskim |
pubmed-article:20830287 | lifeskim:mentions | umls-concept:C1308752 | lld:lifeskim |
pubmed-article:20830287 | lifeskim:mentions | umls-concept:C0005516 | lld:lifeskim |
pubmed-article:20830287 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
pubmed-article:20830287 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
pubmed-article:20830287 | lifeskim:mentions | umls-concept:C1367714 | lld:lifeskim |
pubmed-article:20830287 | lifeskim:mentions | umls-concept:C1706327 | lld:lifeskim |
pubmed-article:20830287 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
pubmed-article:20830287 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
pubmed-article:20830287 | lifeskim:mentions | umls-concept:C0443131 | lld:lifeskim |
pubmed-article:20830287 | pubmed:issue | 9 | lld:pubmed |
pubmed-article:20830287 | pubmed:dateCreated | 2010-9-10 | lld:pubmed |
pubmed-article:20830287 | pubmed:abstractText | The suboptimal sensitivity of Interferon (IFN)-?-based in-vitro assays, especially in immunocompromised individuals, emphasizes the need for alternative markers for diagnosing tuberculosis (TB). The objective of this study was to evaluate whether interferon-inducible protein (IP)-10, monocyte chemotactic protein (MCP)-2 and interleukin (IL)-2 can be useful biomarkers for evaluating a specific response to RD1 antigens associated to active TB disease in HIV-infected individuals. | lld:pubmed |
pubmed-article:20830287 | pubmed:language | eng | lld:pubmed |
pubmed-article:20830287 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20830287 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20830287 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20830287 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20830287 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20830287 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20830287 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20830287 | pubmed:issn | 1932-6203 | lld:pubmed |
pubmed-article:20830287 | pubmed:author | pubmed-author:RodriguesCami... | lld:pubmed |
pubmed-article:20830287 | pubmed:author | pubmed-author:GolettiDeliaD | lld:pubmed |
pubmed-article:20830287 | pubmed:author | pubmed-author:IppolitoGiuse... | lld:pubmed |
pubmed-article:20830287 | pubmed:author | pubmed-author:AlameluRajaR | lld:pubmed |
pubmed-article:20830287 | pubmed:author | pubmed-author:VernetGuyG | lld:pubmed |
pubmed-article:20830287 | pubmed:author | pubmed-author:LagrangePhili... | lld:pubmed |
pubmed-article:20830287 | pubmed:author | pubmed-author:GirardiEnrico... | lld:pubmed |
pubmed-article:20830287 | pubmed:author | pubmed-author:CarraraStefan... | lld:pubmed |
pubmed-article:20830287 | pubmed:author | pubmed-author:LeportierMarc... | lld:pubmed |
pubmed-article:20830287 | pubmed:author | pubmed-author:SodhaArchanaA | lld:pubmed |
pubmed-article:20830287 | pubmed:author | pubmed-author:Syed Ahamed... | lld:pubmed |
pubmed-article:20830287 | pubmed:author | pubmed-author:LonguetChrist... | lld:pubmed |
pubmed-article:20830287 | pubmed:author | pubmed-author:ThangarajSath... | lld:pubmed |
pubmed-article:20830287 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20830287 | pubmed:volume | 5 | lld:pubmed |
pubmed-article:20830287 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20830287 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20830287 | pubmed:pagination | e12577 | lld:pubmed |
pubmed-article:20830287 | pubmed:meshHeading | pubmed-meshheading:20830287... | lld:pubmed |
pubmed-article:20830287 | pubmed:meshHeading | pubmed-meshheading:20830287... | lld:pubmed |
pubmed-article:20830287 | pubmed:meshHeading | pubmed-meshheading:20830287... | lld:pubmed |
pubmed-article:20830287 | pubmed:meshHeading | pubmed-meshheading:20830287... | lld:pubmed |
pubmed-article:20830287 | pubmed:meshHeading | pubmed-meshheading:20830287... | lld:pubmed |
pubmed-article:20830287 | pubmed:meshHeading | pubmed-meshheading:20830287... | lld:pubmed |
pubmed-article:20830287 | pubmed:meshHeading | pubmed-meshheading:20830287... | lld:pubmed |
pubmed-article:20830287 | pubmed:meshHeading | pubmed-meshheading:20830287... | lld:pubmed |
pubmed-article:20830287 | pubmed:meshHeading | pubmed-meshheading:20830287... | lld:pubmed |
pubmed-article:20830287 | pubmed:meshHeading | pubmed-meshheading:20830287... | lld:pubmed |
pubmed-article:20830287 | pubmed:meshHeading | pubmed-meshheading:20830287... | lld:pubmed |
pubmed-article:20830287 | pubmed:meshHeading | pubmed-meshheading:20830287... | lld:pubmed |
pubmed-article:20830287 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20830287 | pubmed:articleTitle | Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? | lld:pubmed |
pubmed-article:20830287 | pubmed:affiliation | Translational Research Unit, Department of Epidemiology and Preclinical Research, Lazzaro Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy. delia.goletti@inmi.it | lld:pubmed |
pubmed-article:20830287 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20830287 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |